Technology

 

SEAL™ is a novel multiplexed antibody library approach with built-in redundancies against failures. From antigen to immunization to hybridoma cell line selection, SEAL™ is a multiplexed library approach for antibody generation. When so many independent antibody projects are simultaneously running for one protein target, there is no chance to fail. Better yet, when a protein is targeted with a collection of diverse antibodies against a collection of diverse epitopes, antibody end-use successes are very much ensured too.